ARROWHEAD PHARMACEUTICALS, INC. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000879407-26-000047
- Form type
- 10-Q
- CIK
- 0000879407
- Primary document
- https://www.sec.gov/Archives/edgar/data/879407/000087940726000047/arwr-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ARROWHEAD PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $337.8M | - | - |
| Operating Income | $-100.5M | - | - |
| Net Income | $-101.9M | - | - |
| Eps Basic | -0.73 | - | - |
| Eps Diluted | -0.73 | - | - |
| Total Assets | $2.3B | - | - |
| Shareholders Equity | $614.0M | - | - |
| Operating Cash Flow | $97.9M | - | - |
| Capital Expenditures | $4.7M | - | - |